637 related articles for article (PubMed ID: 11729726)
1. [Effects of long-term treatment with prostacyclin on plasma adrenomedullin in patients with primary pulmonary hypertension].
Nakayama T; Ishikita T; Matsuura H; Saji T
J Cardiol; 2001 Nov; 38(5):263-71. PubMed ID: 11729726
[TBL] [Abstract][Full Text] [Related]
2. Increased plasma levels of adrenomedullin in patients with pulmonary hypertension.
Kakishita M; Nishikimi T; Okano Y; Satoh T; Kyotani S; Nagaya N; Fukushima K; Nakanishi N; Takishita S; Miyata A; Kangawa K; Matsuo H; Kunieda T
Clin Sci (Lond); 1999 Jan; 96(1):33-9. PubMed ID: 9857104
[TBL] [Abstract][Full Text] [Related]
3. [Short- and long-term effects of the new oral prostacyclin analogue, beraprost sodium, in patients with severe pulmonary hypertension].
Saji T; Ozawa Y; Nakayama T; Matsuura H; Hashiguchi R; Matsuo N; Muto H; Yamazaki J; Morishita T; Saito T
J Cardiol; 1996 Apr; 27(4):197-205. PubMed ID: 8642506
[TBL] [Abstract][Full Text] [Related]
4. [Feasibility of cardiopulmonary rehabilitation in patients with idiopathic pulmonary arterial hypertension treated with intravenous prostacyclin infusion therapy].
Uchi M; Saji T; Harada T
J Cardiol; 2005 Nov; 46(5):183-93. PubMed ID: 16320975
[TBL] [Abstract][Full Text] [Related]
5. Venous endotelin-1 (ET-1) and brain natriuretic peptide (BNP) plasma levels during 6-month bosentan treatment for pulmonary arterial hypertension.
Vizza CD; Letizia C; Petramala L; Badagliacca R; Poscia R; Zepponi E; Crescenzi E; Nona A; Benedetti G; Ferrante F; Sciomer S; Fedele F
Regul Pept; 2008 Nov; 151(1-3):48-53. PubMed ID: 18796317
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of increased plasma levels of brain natriuretic peptide in patients with septic shock.
Ueda S; Nishio K; Akai Y; Fukushima H; Ueyama T; Kawai Y; Masui K; Yoshioka A; Okuchi K
Shock; 2006 Aug; 26(2):134-9. PubMed ID: 16878020
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of exercise capacity with cardiopulmonary exercise test and B-type natriuretic peptide in adults with congenital heart disease.
Trojnarska O; Gwizdała A; Katarzyński S; Katarzyńska A; Szyszka A; Lanocha M; Grajek S; Kramer L
Cardiol J; 2009; 16(2):133-41. PubMed ID: 19387960
[TBL] [Abstract][Full Text] [Related]
8. Increased plasma levels of adrenomedullin in patients with heart failure.
Nishikimi T; Saito Y; Kitamura K; Ishimitsu T; Eto T; Kangawa K; Matsuo H; Omae T; Matsuoka H
J Am Coll Cardiol; 1995 Nov; 26(6):1424-31. PubMed ID: 7594065
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of brain natriuretic peptide in primary pulmonary hypertension.
Leuchte HH; Holzapfel M; Baumgartner RA; Ding I; Neurohr C; Vogeser M; Kolbe T; Schwaiblmair M; Behr J
J Am Coll Cardiol; 2004 Mar; 43(5):764-70. PubMed ID: 14998614
[TBL] [Abstract][Full Text] [Related]
10. Plasma endothelin-1 levels and clinical correlates in patients with chronic heart failure.
Kinugawa T; Kato M; Ogino K; Osaki S; Igawa O; Hisatome I; Shigemasa C
J Card Fail; 2003 Aug; 9(4):318-24. PubMed ID: 13680553
[TBL] [Abstract][Full Text] [Related]
11. Correlations between clinical presentation, brain natriuretic peptide, big endothelin-1, tumor necrosis factor-alpha and cardiac troponins in heart failure patients.
Boffa GM; Zaninotto M; Bacchiega E; Nalli C; Forni M; Tiso E; Cacciavillani L; Razzolini R; Plebani M
Ital Heart J; 2005 Feb; 6(2):125-32. PubMed ID: 15819505
[TBL] [Abstract][Full Text] [Related]
12. Effects of exercise testing on natriuretic peptide secretion in patients with atrial fibrillation.
Wozakowska-Kapłon B; Opolski G
Kardiol Pol; 2009 Mar; 67(3):254-61. PubMed ID: 19378231
[TBL] [Abstract][Full Text] [Related]
13. Intravenous epoprostenol in inoperable chronic thromboembolic pulmonary hypertension.
Cabrol S; Souza R; Jais X; Fadel E; Ali RH; Humbert M; Dartevelle P; Simonneau G; Sitbon O
J Heart Lung Transplant; 2007 Apr; 26(4):357-62. PubMed ID: 17403477
[TBL] [Abstract][Full Text] [Related]
14. Baseline and serial neurohormones in patients with congestive heart failure treated with and without bucindolol: results of the neurohumoral substudy of the Beta-Blocker Evaluation of Survival Study (BEST).
Frantz RP; Lowes BD; Grayburn PA; White M; Krause-Steinrauf H; Krishnan V; Uyeda L; Burnett JC;
J Card Fail; 2007 Aug; 13(6):437-44. PubMed ID: 17675057
[TBL] [Abstract][Full Text] [Related]
15. N-terminal pro-B-type natriuretic peptide as an indicator of disease severity in a heterogeneous group of patients with chronic precapillary pulmonary hypertension.
Andreassen AK; Wergeland R; Simonsen S; Geiran O; Guevara C; Ueland T
Am J Cardiol; 2006 Aug; 98(4):525-9. PubMed ID: 16893710
[TBL] [Abstract][Full Text] [Related]
16. Vasoactive peptides during long-term follow-up of patients after cardiac transplantation.
Kirchhoff WCh; Gradaus R; Stypmann J; Deng MC; Tian TD; Scheld HH; Breithardt G; Brisse B
J Heart Lung Transplant; 2004 Mar; 23(3):284-8. PubMed ID: 15019637
[TBL] [Abstract][Full Text] [Related]
17. Exercise improvement and plasma biomarker changes with intravenous treprostinil therapy for pulmonary arterial hypertension: a placebo-controlled trial.
Hiremath J; Thanikachalam S; Parikh K; Shanmugasundaram S; Bangera S; Shapiro L; Pott GB; Vnencak-Jones CL; Arneson C; Wade M; White RJ;
J Heart Lung Transplant; 2010 Feb; 29(2):137-49. PubMed ID: 20022264
[TBL] [Abstract][Full Text] [Related]
18. Possible vascular role of increased plasma arginine vasopressin in congestive heart failure.
Nakamura T; Funayama H; Yoshimura A; Tsuruya Y; Saito M; Kawakami M; Ishikawa SE
Int J Cardiol; 2006 Jan; 106(2):191-5. PubMed ID: 16321691
[TBL] [Abstract][Full Text] [Related]
19. [Acute changes in the hemodynamic profile and circulating levels of atrial natriuretic peptide induced by dobutamine in severe heart failure].
La Vecchia L; Bottero M; Centofante P; Bedogni F; Ometto R; Cera A; Fortunato A
G Ital Cardiol; 1996 Aug; 26(8):863-74. PubMed ID: 9005168
[TBL] [Abstract][Full Text] [Related]
20. [Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension].
Nagaya N; Nishikimi T; Uematsu M; Satoh T; Kyotani S; Sakamaki F; Kakishita M; Fukushima K; Okano Y; Nakanishi N; Miyatake K; Kangawa K
J Cardiol; 2001 Feb; 37(2):110-1. PubMed ID: 11255693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]